Sendai, Japan

Toshikazu Awataguchi


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshikazu Awataguchi: Innovator in Granulocyte Differentiation

Introduction

Toshikazu Awataguchi is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of medical science, particularly in the differentiation of human peripheral blood granulocytes. His innovative methods have the potential to enhance patient care and disease monitoring.

Latest Patents

Awataguchi holds a patent for a method that differentiates human peripheral blood granulocytes. This method involves cultivating granulocytes in the presence of an interferon and applying an immune complex along with a chemiluminescent substance. The chemiluminescent amounts induced are then measured. This invention is crucial for screening patients suffering from serious infectious diseases and various inflammations. It also offers advantages in monitoring the curative effects for these patients. He has 1 patent to his name.

Career Highlights

Toshikazu Awataguchi is currently employed at Pola Chemical Industries, Inc. His work at this company has allowed him to focus on innovative research and development in the medical field. His expertise and dedication have made him a valuable asset to his team.

Collaborations

Awataguchi has collaborated with notable colleagues, including Toshiro Majima and Ryoichi Nagatomi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Toshikazu Awataguchi's contributions to the differentiation of human peripheral blood granulocytes highlight his role as an innovator in medical science. His work not only advances research but also has the potential to improve patient outcomes significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…